Variant report

Variant	esv3332947
Chromosome Location	chr19:18745902-18749700
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:417)
CpG islands
(count:672)
Chromatin interactive
region (count:20)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:417 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr19:18747519-18747929	K562	blood:	n/a	n/a
2	ATF3	chr19:18747762-18747941	GM12878	blood:	n/a	n/a
3	ATF3	chr19:18747756-18747997	K562	blood:	n/a	n/a
4	BACH1	chr19:18747805-18747960	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr19:18747309-18747344	K562	blood:	n/a	n/a
6	BHLHE40	chr19:18747885-18747926	K562	blood:	n/a	n/a
7	BHLHE40	chr19:18746835-18747478	K562	blood:	n/a	chr19:18747037-18747046
8	BHLHE40	chr19:18745789-18746151	HepG2	liver:	n/a	n/a
9	BHLHE40	chr19:18745749-18746115	K562	blood:	n/a	n/a
10	BHLHE40	chr19:18746866-18747411	HepG2	liver:	n/a	chr19:18747037-18747046
11	BHLHE40	chr19:18746864-18747605	GM12878	blood:	n/a	chr19:18747037-18747046
12	BRCA1	chr19:18747417-18747501	HepG2	liver:	n/a	n/a
13	BRCA1	chr19:18747315-18747432	Hela-S3	cervix:	n/a	n/a
14	CBX3	chr19:18747093-18747690	K562	blood:	n/a	n/a
15	CCNT2	chr19:18747288-18748028	K562	blood:	n/a	chr19:18747761-18747770
16	CHD1	chr19:18747892-18747957	GM12878	blood:	n/a	n/a
17	CHD2	chr19:18746902-18747891	Hela-S3	cervix:	n/a	n/a
18	CHD2	chr19:18748693-18748728	GM12878	blood:	n/a	n/a
19	CHD2	chr19:18747272-18747503	K562	blood:	n/a	n/a
20	CHD2	chr19:18747906-18748052	K562	blood:	n/a	n/a
21	CREB1	chr19:18747530-18748171	K562	blood:	n/a	n/a
22	CREB1	chr19:18746990-18748208	GM12878	blood:	n/a	n/a
23	CREB1	chr19:18746976-18748182	K562	blood:	n/a	n/a
24	CREB1	chr19:18747642-18748063	ECC-1	luminal epithelium:	n/a	n/a
25	CREB1	chr19:18746769-18748180	HepG2	liver:	n/a	n/a
26	CREB1	chr19:18747541-18748205	H1-hESC	embryonic stem cell:	n/a	n/a
27	CREB1	chr19:18747509-18747978	A549	lung:	n/a	n/a
28	CREB1	chr19:18747416-18748097	H1-hESC	embryonic stem cell:	n/a	n/a
29	CTCF	chr19:18748632-18748794	GM12891	blood:	n/a	n/a
30	CTCF	chr19:18747302-18747605	H1-hESC	embryonic stem cell:	n/a	n/a
31	CTCF	chr19:18748657-18748793	K562	blood:	n/a	n/a
32	CTCF	chr19:18746060-18746210	HEK293	kidney:	n/a	chr19:18746163-18746171
33	CTCF	chr19:18746160-18746310	AG04450	lung:	n/a	chr19:18746163-18746171
34	CTCF	chr19:18748622-18748796	Hela-S3	cervix:	n/a	n/a
35	CTCF	chr19:18748638-18748743	GM10248	blood:	n/a	n/a
36	CTCF	chr19:18746060-18746210	HepG2	liver:	n/a	chr19:18746163-18746171
37	CTCF	chr19:18746105-18746164	MCF-7	breast:	n/a	n/a
38	CTCF	chr19:18748651-18748704	Lung_OC	lung:	n/a	n/a
39	CTCF	chr19:18748640-18748790	HRPEpiC	eye:	n/a	n/a
40	CTCF	chr19:18748560-18748710	GM12873	blood:	n/a	n/a
41	CTCF	chr19:18748560-18748710	GM06990	blood:	n/a	n/a
42	CTCF	chr19:18745960-18746110	HPAF	blood vessel:	n/a	n/a
43	CTCF	chr19:18748634-18748796	GM12878	blood:	n/a	n/a
44	CTCF	chr19:18748638-18748785	IMR90	lung:	n/a	n/a
45	CTCF	chr19:18748560-18748710	GM12875	blood:	n/a	n/a
46	CTCF	chr19:18748659-18748749	Gliobla	brain:	n/a	n/a
47	CTCF	chr19:18748625-18748746	GM10266	blood:	n/a	n/a
48	CTCF	chr19:18746020-18746170	WERI-Rb-1	eye:	n/a	n/a
49	CTCF	chr19:18748664-18748753	A549	lung:	n/a	n/a
50	CTCF	chr19:18748668-18748735	ProgFib	skin:	n/a	n/a

(count:672 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:18746981-18747031	HEEpiC	esophagus:	n/a
2	chr19:18746981-18747031	HEEpiC	esophagus:	n/a
3	chr19:18747704-18747754	MCF10A-Er-Src	breast:	n/a
4	chr19:18747721-18747771	U87	brain:	n/a
5	chr19:18746981-18747031	MCF-7	breast:	n/a
6	chr19:18747704-18747754	SK-N-MC	brain:	n/a
7	chr19:18745971-18746021	HCF	heart:	n/a
8	chr19:18746992-18747042	GM19239	blood:	n/a
9	chr19:18746981-18747031	HRCEpiC	kidney:	n/a
10	chr19:18747733-18747783	SKMC	muscle:	n/a
11	chr19:18748017-18748067	AG04449	skin:	fetal
12	chr19:18747733-18747783	ProgFib	skin:	n/a
13	chr19:18747721-18747771	MCF-7	breast:	n/a
14	chr19:18748017-18748067	Hela-S3	cervix:	n/a
15	chr19:18747619-18747669	NB4	blood:	n/a
16	chr19:18747704-18747754	SK-N-SH_RA	brain:	n/a
17	chr19:18747691-18747741	HNPCEpiC	eye:	n/a
18	chr19:18745971-18746021	GM06990	blood:	n/a
19	chr19:18747727-18747777	HEEpiC	esophagus:	n/a
20	chr19:18747691-18747741	T-47D	breast:	n/a
21	chr19:18746992-18747042	PrEC	prostate:	n/a
22	chr19:18747721-18747771	SKMC	muscle:	n/a
23	chr19:18747727-18747777	GM06990	blood:	n/a
24	chr19:18747733-18747783	ovcar-3	ovarian:	n/a
25	chr19:18747727-18747777	U87	brain:	n/a
26	chr19:18748017-18748067	ECC-1	luminal epithelium:	n/a
27	chr19:18747733-18747783	U87	brain:	n/a
28	chr19:18746981-18747031	PANC-1	pancreas:	n/a
29	chr19:18746985-18747035	HMEC	breast:	n/a
30	chr19:18747691-18747741	PrEC	prostate:	n/a
31	chr19:18747619-18747669	HRPEpiC	eye:	n/a
32	chr19:18748017-18748067	HCT-116	colon:	n/a
33	chr19:18747721-18747771	HAEpiC	amniotic membrane:	n/a
34	chr19:18745971-18746021	GM12878	blood:	n/a
35	chr19:18746981-18747031	NT2-D1	testis:	n/a
36	chr19:18747721-18747771	HRPEpiC	eye:	n/a
37	chr19:18747619-18747669	HEEpiC	esophagus:	n/a
38	chr19:18747727-18747777	HCM	heart:	n/a
39	chr19:18747704-18747754	MCF-7	breast:	n/a
40	chr19:18747704-18747754	HL-60	blood:	n/a
41	chr19:18747721-18747771	GM12892	blood:	n/a
42	chr19:18746985-18747035	MCF10A-Er-Src	breast:	n/a
43	chr19:18746981-18747031	T-47D	breast:	n/a
44	chr19:18745971-18746021	K562	blood:	n/a
45	chr19:18747619-18747669	ECC-1	luminal epithelium:	n/a
46	chr19:18747704-18747754	T-47D	breast:	n/a
47	chr19:18746981-18747031	ECC-1	luminal epithelium:	n/a
48	chr19:18745971-18746021	T-47D	breast:	n/a
49	chr19:18747704-18747754	AG04449	skin:	fetal
50	chr19:18747619-18747669	HCM	heart:	n/a

(count:20 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:18716807..18719687-chr19:18745756..18748857,3	K562	blood:
2	chr19:18738729..18743227-chr19:18745299..18749316,6	K562	blood:
3	chr19:18717575..18719687-chr19:18746806..18748857,2	K562	blood:
4	chr19:18630375..18633112-chr19:18747617..18750132,3	K562	blood:
5	chr19:18746749..18750617-chr19:18752436..18756057,4	K562	blood:
6	chr19:18747079..18749227-chr19:18751650..18755741,5	MCF-7	breast:
7	chr19:18698512..18700358-chr19:18745222..18750244,4	K562	blood:
8	chr19:18681409..18685264-chr19:18744559..18747664,3	MCF-7	breast:
9	chr19:18745231..18747115-chr19:18793241..18795774,2	MCF-7	breast:
10	chr19:18700524..18703188-chr19:18747828..18749371,2	K562	blood:
11	chr19:18703681..18707981-chr19:18746387..18750076,5	K562	blood:
12	chr19:18704018..18706684-chr19:18745467..18747163,2	MCF-7	breast:
13	chr19:18740493..18743219-chr19:18745834..18748100,2	K562	blood:
14	chr19:18739642..18741715-chr19:18744659..18746767,2	MCF-7	breast:
15	chr19:18698708..18701515-chr19:18746316..18749182,4	MCF-7	breast:
16	chr19:18744967..18748846-chr19:18753096..18757449,4	MCF-7	breast:
17	chr19:18699138..18701400-chr19:18744196..18746923,2	K562	blood:
18	chr19:18744815..18748522-chr19:18792822..18794594,3	K562	blood:
19	chr19:18681104..18684544-chr19:18745683..18749906,4	K562	blood:
20	chr19:18553947..18555891-chr19:18746913..18749059,2	K562	blood:

No data

Variant related genes	Relation type
KLHL26	TF binding region
RN7SL155P	TF binding region
KLHL26	CpG island
RN7SL155P	CpG island
ENSG00000105696	chromatin interactions
ENSG00000006015	chromatin interactions
ENSG00000105662	chromatin interactions
ENSG00000256989	chromatin interactions
ENSG00000263490	chromatin interactions
ENSG00000167487	chromatin interactions
ENSG00000006016	chromatin interactions
ENSG00000105656	chromatin interactions
ENSG00000221983	chromatin interactions

Extended variants
information (count: 128 )
Associated
traits (count: 59 )

Variant overlapped rSNPs/rCNVs (count:128 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs145923790	chr19:18745938-18745939	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
2	rs61276834	chr19:18745939-18745940	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
3	rs556974972	chr19:18745940-18745941	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
4	rs397947952	chr19:18745955-18745956	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
5	rs550499219	chr19:18745972-18745973	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
6	rs149648089	chr19:18745988-18745989	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
7	rs538653960	chr19:18745989-18745990	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
8	rs558236945	chr19:18745995-18745996	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
9	rs181923721	chr19:18746022-18746023	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
10	rs144389712	chr19:18746054-18746055	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
11	rs554345722	chr19:18746065-18746066	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
12	rs114724345	chr19:18746102-18746103	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
13	rs185897432	chr19:18746143-18746144	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
14	rs557256110	chr19:18746144-18746145	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
15	rs577043391	chr19:18746157-18746158	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
16	rs565735023	chr19:18746158-18746159	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
17	rs545407321	chr19:18746205-18746206	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
18	rs565246149	chr19:18746209-18746210	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
19	rs76260473	chr19:18746248-18746249	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
20	rs541493878	chr19:18746249-18746250	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
21	rs190453607	chr19:18746295-18746296	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
22	rs537131128	chr19:18746363-18746364	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
23	rs182692270	chr19:18746385-18746386	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
24	rs575483746	chr19:18746401-18746402	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
25	rs74598573	chr19:18746437-18746438	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
26	rs80354959	chr19:18746465-18746466	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
27	rs11668617	chr19:18746522-18746523	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS	Chromatin interactive region	7 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
28	rs111263753	chr19:18746527-18746528	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
29	rs565286805	chr19:18746542-18746543	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
30	rs534314048	chr19:18746547-18746548	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
31	rs547920452	chr19:18746548-18746549	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
32	rs78041499	chr19:18746576-18746577	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
33	rs1991017	chr19:18746593-18746594	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs143014528	chr19:18746626-18746627	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
35	rs539314104	chr19:18746668-18746669	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
36	rs558998532	chr19:18746771-18746772	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
37	rs185391903	chr19:18746831-18746832	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
38	rs541430267	chr19:18746846-18746847	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
39	rs561404774	chr19:18746968-18746969	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
40	rs574808794	chr19:18747046-18747047	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
41	rs117009988	chr19:18747048-18747049	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
42	rs563688034	chr19:18747120-18747121	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
43	rs147445774	chr19:18747143-18747144	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
44	rs532841171	chr19:18747161-18747162	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
45	rs77267035	chr19:18747168-18747169	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
46	rs559608926	chr19:18747180-18747181	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
47	rs528108258	chr19:18747187-18747188	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
48	rs547760785	chr19:18747199-18747200	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
49	rs567837959	chr19:18747232-18747233	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
50	rs75473975	chr19:18747244-18747245	Active TSS Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:59)

Disease	PMID	Source
Medulloblastoma	16783165	CNVD
Follicular lymphoma	20505157	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Non-syndromic sensorineural hearing loss	20179077	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	21080181	CNVD
Metanephric adenoma	20802469	CNVD
Prostate cancer	16573809	CNVD
Breast cancer	16608533	CNVD
Lung cancer	17297452	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Chordoma	18071362	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Oligodendroglial tumors	17285580	CNVD
Oral cancer	21386901	CNVD
ovarian endometriomas	16273235	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Cervical cancer	21063398	CNVD
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Ovarian cancer	21720365	CNVD
Urothelial carcinoma	21177765	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Basal cell lymphoma	21115979	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Medullary thyroid carcinoma	18765511	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Breast cancer	21364760	CNVD
Mycobacterial infection	18421352	CNVD
Glioblastoma multiforme	22286061	CNVD
Acute monocytic leukemia	16498392	CNVD
Lung cancer	18438408	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Liver carcinoma	19366792	CNVD
Colorectal cancer	19455253	CNVD
Lujan-Fryns syndrom	21521776	CNVD
Breast cancer	20409316	CNVD
Cancer	17160897	CNVD
Cancer	17440070	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Breast cancer	21509527	CNVD
Breast cancer	22522925	CNVD
Bladder cancer	21909424	CNVD

Chromatin state (count:693 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:18725600-18747200	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
2	chr19:18729400-18747200	Weak transcription	Brain Angular Gyrus	brain
3	chr19:18740600-18746600	Weak transcription	Fetal Brain Female	brain
4	chr19:18740800-18746000	Weak transcription	Brain Cingulate Gyrus	brain
5	chr19:18740800-18746600	Weak transcription	Brain Anterior Caudate	brain
6	chr19:18740800-18746600	Weak transcription	Brain Substantia Nigra	brain
7	chr19:18740800-18747200	Weak transcription	Brain Hippocampus Middle	brain
8	chr19:18740800-18747200	Weak transcription	Skeletal Muscle Female	skeletal muscle
9	chr19:18741200-18746800	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
10	chr19:18741200-18747200	Weak transcription	Adipose Nuclei	Adipose
11	chr19:18744400-18746200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
12	chr19:18744600-18746200	Weak transcription	Pancreas	Pancrea
13	chr19:18744800-18746000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
14	chr19:18744800-18746000	Weak transcription	Rectal Mucosa Donor 29	rectum
15	chr19:18745200-18746600	Bivalent Enhancer	Fetal Muscle Leg	muscle
16	chr19:18745600-18746000	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
17	chr19:18745600-18746000	Enhancers	Left Ventricle	heart
18	chr19:18745600-18746000	Enhancers	Lung	lung
19	chr19:18745600-18746000	Bivalent Enhancer	NHDF-Ad	bronchial
20	chr19:18745600-18746200	Active TSS	Fetal Kidney	kidney
21	chr19:18745600-18746200	Enhancers	Pancreatic Islets	Pancreatic Islet
22	chr19:18745600-18746200	Bivalent Enhancer	Fetal Thymus	thymus
23	chr19:18745600-18746200	Bivalent Enhancer	K562	blood
24	chr19:18745600-18746400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
25	chr19:18745600-18746400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
26	chr19:18745600-18746400	Bivalent Enhancer	Fetal Stomach	stomach
27	chr19:18745600-18746600	Enhancers	Duodenum Mucosa	Duodenum
28	chr19:18745600-18746600	Enhancers	Esophagus	oesophagus
29	chr19:18745600-18746600	Enhancers	Fetal Lung	lung
30	chr19:18745600-18746600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
31	chr19:18745600-18746600	Bivalent Enhancer	Placenta	Placenta
32	chr19:18745600-18746800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
33	chr19:18745600-18746800	Enhancers	Right Ventricle	heart
34	chr19:18745600-18746800	Flanking Active TSS	HepG2	liver
35	chr19:18745600-18747000	Enhancers	Primary T helper cells PMA-I stimulated	--
36	chr19:18745600-18747200	Enhancers	Primary T cells fromperipheralblood	blood
37	chr19:18745600-18747200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
38	chr19:18745600-18747200	Enhancers	Rectal Mucosa Donor 31	rectum
39	chr19:18745600-18747200	Enhancers	NHEK	skin
40	chr19:18745600-18747800	Enhancers	Fetal Brain Male	brain
41	chr19:18745800-18746000	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
42	chr19:18745800-18746000	Bivalent Enhancer	Fetal Intestine Small	intestine
43	chr19:18745800-18746000	Enhancers	Spleen	Spleen
44	chr19:18745800-18746200	Flanking Bivalent TSS/Enh	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
45	chr19:18745800-18746400	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
46	chr19:18745800-18746600	Enhancers	Right Atrium	heart
47	chr19:18745800-18746800	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
48	chr19:18745800-18746800	Enhancers	Primary hematopoietic stem cells	blood
49	chr19:18745800-18747200	Enhancers	Primary T cells from cord blood	blood
50	chr19:18745800-18747200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links